Trulicity (Dulaglutide) Injection

Trulicity (Dulaglutide) Injection

€284.95

Trulicity (dulaglutide) is a once-weekly GLP-1 injection used to improve blood sugar control in adults with type 2 diabetes and provides additional cardiovascular benefits.

Trulicity (Dulaglutide) Injection

Once-weekly GLP-1 receptor agonist for improving blood glucose control in adults with type 2 diabetes.

Trulicity offers a convenient, clinically validated approach to managing blood sugar levels, particularly when combined with lifestyle modifications such as diet and exercise.

Overview of Trulicity for Type 2 Diabetes Management

Trulicity (dulaglutide) is a prescription injectable medicine designed to support glycaemic control in adults diagnosed with type 2 diabetes mellitus. It is administered once weekly and is commonly prescribed when lifestyle interventions alone are insufficient.

Belonging to the class of GLP-1 receptor agonists, Trulicity works by mimicking naturally occurring hormones that regulate blood sugar. In addition to glucose control, it may contribute to weight reduction and has been shown to reduce the risk of major cardiovascular events in certain patients.

Guidance from the National Institute for Health and Care Excellence (NICE) and the European Medicines Agency (EMA) supports the use of GLP-1 receptor agonists in appropriate individuals with type 2 diabetes.

Mechanism of Action: How Trulicity Works

GLP-1 Hormone Mimicry

Dulaglutide replicates the effects of the glucagon-like peptide-1 (GLP-1) hormone, which plays a crucial role in glucose regulation.

  • Stimulates insulin secretion: Enhances insulin release when blood glucose levels are elevated
  • Suppresses glucagon: Reduces hepatic glucose production
  • Slows gastric emptying: Helps prevent post-meal glucose spikes

This multi-faceted action contributes to more stable blood sugar levels throughout the day.

Dosage and Administration

Available Strengths

Trulicity is supplied in prefilled, single-use injection pens in the following strengths:

  • 0.75 mg
  • 1.5 mg
  • 3 mg
  • 4.5 mg

Typical Dosing Schedule

Treatment generally begins at 0.75 mg once weekly. Based on clinical response and tolerability, your healthcare provider may gradually increase the dose.

Administration Guidelines

  • Administer via subcutaneous injection once weekly
  • Inject into the abdomen, thigh, or upper arm
  • Rotate injection sites weekly to avoid irritation
  • Do not mix with insulin or inject into the same site as other medicines

Missed Dose Advice

If a dose is missed, it may be administered as soon as possible, provided there are at least 72 hours before the next scheduled dose.

Clinical Benefits and Therapeutic Effects

  • Improves glycaemic control in adults with type 2 diabetes
  • Reduces postprandial glucose excursions
  • May support modest weight reduction
  • Demonstrated cardiovascular risk reduction in high-risk patients

Clinical trials and regulatory evaluations have confirmed the efficacy of dulaglutide in long-term diabetes management.

Common Side Effects

Like all medicines, Trulicity may cause side effects, particularly during the early stages of treatment.

  • Nausea
  • Diarrhoea
  • Abdominal discomfort
  • Reduced appetite
  • Fatigue

These effects are typically mild to moderate and may diminish over time as the body adjusts to treatment.

Serious Side Effects and Safety Warnings

Although rare, serious adverse reactions may occur and require urgent medical attention:

  • Pancreatitis: Persistent severe abdominal pain
  • Thyroid tumours: Unusual neck swelling or difficulty swallowing
  • Severe allergic reactions: Facial swelling or breathing difficulties

Patients should immediately seek medical care if any of these symptoms develop.

Precautions and Contraindications

Inform Your Healthcare Provider If You Have:

  • History of thyroid cancer
  • Gastrointestinal disorders
  • Renal or hepatic impairment
  • Cardiovascular conditions

Contraindications

Trulicity must not be used in individuals with:

  • Medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)

Drug Interactions and Combination Therapy

Trulicity is frequently used alongside other glucose-lowering medicines such as metformin or basal insulin. However, dose adjustments may be required to reduce the risk of hypoglycaemia.

Always inform your clinician about all medications, supplements, and herbal products you are taking.

Guidance on Buying Trulicity Online

Purchasing Trulicity online may provide cost advantages, but safety must remain a priority.

  • Consult your healthcare provider before ordering
  • Use only licensed and regulated pharmacies
  • Ensure prescriptions are valid and compliant with regulations

Refer to regulatory advice from the MHRA regarding safe online medicine purchasing.

Storage and Handling Instructions

  • Store in a refrigerator at 2°C to 8°C
  • May be kept at room temperature (below 30°C) for up to 14 days
  • Do not freeze
  • Keep away from direct sunlight

How to Use Trulicity Injection Pens

Trulicity is supplied in a ready-to-use prefilled pen requiring no mixing.

  1. Select an appropriate injection site
  2. Clean the area with an alcohol swab
  3. Administer the injection under the skin
  4. Dispose of the pen safely after use

Always use a new needle for each administration and follow your healthcare provider’s instructions.

Frequently Asked Questions (FAQs)

Is Trulicity used for weight loss?

Although primarily indicated for type 2 diabetes, some individuals may experience weight loss due to appetite suppression.

Is a generic version available?

Currently, there is no approved generic equivalent of Trulicity.

Can it be used with other diabetes treatments?

Yes, it is often combined with other therapies such as metformin or insulin, under medical supervision.

Internal Resources

Disclaimer

This content is for informational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting or changing treatment.

References

Tags

Trulicity, dulaglutide, GLP-1 injection, type 2 diabetes, blood sugar control, Trulicity injection, dulaglutide diabetes treatment, GLP-1 receptor agonist UK, weekly diabetes injection, blood glucose control medication

Scroll to Top